Angion Biomedica Corp ANGN:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 3:40 PM EST
17.75quote price arrow down-3.64 (-17.02%)
Volume
195,726
52 week range
16.00 - 26.30

...

Loading . . .

KEY STATS

  • Open21.11
  • Day High21.40
  • Day Low17.70
  • Prev Close21.39
  • 52 Week High26.30
  • 52 Week High Date02/19/21
  • 52 Week Low16.00
  • 52 Week Low Date02/08/21
  • Market Cap509.78M
  • Shares Out28.72M
  • 10 Day Average Volume0.16M
  • Dividend-
  • Dividend Yield-
  • Beta
  • 1 Year % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-4.08
  • P/E (TTM)-4.36
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-55.512M
  • ROE (MRQ)-
  • Revenue (MRQ)3.12M
  • Gross Margin (MRQ)56.27%
  • Net Margin (MRQ)-2,157.43%
  • Debt To Equity (MRQ)-65.55%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Angion Biomedica Corp News

There is no recent news for this security.

Latest ANGN News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Angion Biomedica Corp. is a late-stage biopharmaceutical company. The Company focuses on discovery, development and commercialization of small molecule therapeutics to address acute organ injuries and fibrotic diseases. The Company’s lead product candidate is ANG-3777. Its pipeline includes ANG-3070, rho kinase 2 (ROCK2), and CYP11B2. Its ANG-3777 is a hepatocyte growth factor (HGF) mimetic it is evaluating in multiple acute organ injuries and related indications, including...
Address
51 Charles Lindbergh Boulevard
Suite 1200
Uniondale, NY
11553
United States